Ulf Göran Richenberg
Presidente presso KCIF Fund Management AB
Posizioni attive di Ulf Göran Richenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
KCIF Fund Management AB | Presidente | 21/04/2011 | - |
KD Incentive AB | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Ulf Göran Richenberg
Precedenti posizioni note di Ulf Göran Richenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
KAROLINSKA DEVELOPMENT AB | Consigliere Generale | 01/01/2008 | 01/05/2020 |
Segretario Aziendale | - | 01/05/2020 | |
AB Stokab | Consigliere Generale | 12/12/2003 | 12/12/2003 |
Scribona AB
Scribona AB Computer Processing HardwareElectronic Technology Scribona AB manufactures and distributes computers, operating systems, servers, and network products. The company's principal activities are the retail and distribution of computer products and high-tech office equipment such as PCs, handheld devices, printers, software and accessories.The company produces office products, office electronics information services in the Nordic countries. The company has five subsidiaries in Sweden, Luxemburg, UK, Finland and Norway. The company was founded in 1992 and is headquartered in Stockholm, Sweden | Consigliere Generale | 01/05/1995 | 01/05/1995 |
Esselte AB
Esselte AB Office Equipment/SuppliesProducer Manufacturing Esselte AB manufactures office solutions. It sells office products and graphics products. The company was founded on April 18, 1913 and is headquartered in Solna, Sweden. | Consigliere Generale | 01/08/1989 | 01/07/1992 |
Vattenfall AB
Vattenfall AB Electric UtilitiesUtilities Vattenfall AB engages in the generation, distribution, and sale of heat and electricity. It operates through the following segments: Heat, Customers and Solutions, Wind, Power Generation, and Distribution. The company was founded in 1909 and is headquartered in Solna, Sweden. | Consigliere Generale | 01/10/1984 | 01/09/1989 |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Presidente | - | - |
Avaris AB
Avaris AB Miscellaneous Commercial ServicesCommercial Services Avaris was founded in 2001 by research teams at the Karolinska Institute and Karolinska Innovations AB. The company is based on four proprietary technology platforms within cell and gene therapy. Avaris drives the research development and commercialization of new therapies in close collaboration with the founders, research teams, and strategic partners. The company is well positioned in cell and gene therapy field for chronic infections, cancer and inherited diseases. Avaris vision is to become the number one supplier of individualized cell and gene therapy treatments in northern Europe. In order to reach this goal it is exploring possibilities to acquire, or in license cell therapy technologies that complement the in house growth. Avaris is also open to partnering possibilities. | Direttore/Membro del Consiglio | - | - |
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░ ░░░░░░░ | - | - |
Statistiche
Distribuzione geografica
Svezia | 11 |
Posizioni
General Counsel | 6 |
Chairman | 2 |
Director/Board Member | 2 |
Settori
Utilities | 2 |
Electronic Technology | 2 |
Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
KAROLINSKA DEVELOPMENT AB | Finance |
Aziende private | 9 |
---|---|
Vattenfall AB
Vattenfall AB Electric UtilitiesUtilities Vattenfall AB engages in the generation, distribution, and sale of heat and electricity. It operates through the following segments: Heat, Customers and Solutions, Wind, Power Generation, and Distribution. The company was founded in 1909 and is headquartered in Solna, Sweden. | Utilities |
Scribona AB
Scribona AB Computer Processing HardwareElectronic Technology Scribona AB manufactures and distributes computers, operating systems, servers, and network products. The company's principal activities are the retail and distribution of computer products and high-tech office equipment such as PCs, handheld devices, printers, software and accessories.The company produces office products, office electronics information services in the Nordic countries. The company has five subsidiaries in Sweden, Luxemburg, UK, Finland and Norway. The company was founded in 1992 and is headquartered in Stockholm, Sweden | Electronic Technology |
Karolinska Institutet Holding AB
Karolinska Institutet Holding AB Investment Trusts/Mutual FundsMiscellaneous Part of Karolinska Institutet Holding AB, Nätverk Karolinska Institutet Science Park AB (KISP) facilitates interaction between academia and industry on Campus Solna. The company is based in Solna, Sweden. KISP collaborates closely with Karolinska Institutet, Akademiska Hus, and AWL to organize seminars, workshops, and networking events that help researchers, startups, and established companies connect and gain new insights. The CEO of the Swedish company is Karl Johan Ingvar Weigelt. | Miscellaneous |
Avaris AB
Avaris AB Miscellaneous Commercial ServicesCommercial Services Avaris was founded in 2001 by research teams at the Karolinska Institute and Karolinska Innovations AB. The company is based on four proprietary technology platforms within cell and gene therapy. Avaris drives the research development and commercialization of new therapies in close collaboration with the founders, research teams, and strategic partners. The company is well positioned in cell and gene therapy field for chronic infections, cancer and inherited diseases. Avaris vision is to become the number one supplier of individualized cell and gene therapy treatments in northern Europe. In order to reach this goal it is exploring possibilities to acquire, or in license cell therapy technologies that complement the in house growth. Avaris is also open to partnering possibilities. | Commercial Services |
KCIF Fund Management AB | |
Esselte AB
Esselte AB Office Equipment/SuppliesProducer Manufacturing Esselte AB manufactures office solutions. It sells office products and graphics products. The company was founded on April 18, 1913 and is headquartered in Solna, Sweden. | Producer Manufacturing |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Health Technology |
AB Stokab | |
KD Incentive AB |
- Borsa valori
- Insiders
- Ulf Göran Richenberg
- Esperienza